ClearPoint Neuro, Inc. (CLPT)
USD 15.08
(-7.71%)
USD 15.08
(-7.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.94 Million USD | 16.31% |
| 2022 | 11.98 Million USD | -2.43% |
| 2021 | 12.28 Million USD | -49.33% |
| 2020 | 24.24 Million USD | 884.34% |
| 2019 | 2.46 Million USD | -29.24% |
| 2018 | 3.48 Million USD | -29.23% |
| 2017 | 4.91 Million USD | 9.49% |
| 2016 | 4.49 Million USD | -44.63% |
| 2015 | 8.11 Million USD | 5.49% |
| 2014 | 7.69 Million USD | -8.7% |
| 2013 | 8.42 Million USD | 28.91% |
| 2012 | 6.53 Million USD | -12.37% |
| 2011 | 7.45 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 13.79 Million USD | -0.73% |
| 2024 Q1 | 13.89 Million USD | -0.3% |
| 2023 Q4 | 13.94 Million USD | -0.52% |
| 2023 Q3 | 14.01 Million USD | -1.79% |
| 2023 FY | 13.94 Million USD | 16.31% |
| 2023 Q2 | 14.26 Million USD | 20.27% |
| 2023 Q1 | 11.86 Million USD | -1.02% |
| 2022 Q3 | 11.95 Million USD | -0.97% |
| 2022 Q4 | 11.98 Million USD | 0.29% |
| 2022 FY | 11.98 Million USD | -2.43% |
| 2022 Q1 | 12.17 Million USD | -0.86% |
| 2022 Q2 | 12.06 Million USD | -0.9% |
| 2021 Q3 | 20.17 Million USD | 0.0% |
| 2021 Q4 | 12.28 Million USD | -39.1% |
| 2021 Q1 | 27.27 Million USD | 12.5% |
| 2021 Q2 | 20.16 Million USD | -26.05% |
| 2021 FY | 12.28 Million USD | -49.33% |
| 2020 Q1 | 17.14 Million USD | 596.2% |
| 2020 Q2 | 18.04 Million USD | 5.27% |
| 2020 Q3 | 18.05 Million USD | 0.06% |
| 2020 Q4 | 24.24 Million USD | 34.24% |
| 2020 FY | 24.24 Million USD | 884.34% |
| 2019 FY | 2.46 Million USD | -29.24% |
| 2019 Q1 | 4.12 Million USD | 18.4% |
| 2019 Q3 | 2.28 Million USD | -1.5% |
| 2019 Q2 | 2.31 Million USD | -43.82% |
| 2019 Q4 | 2.46 Million USD | 8.0% |
| 2018 Q2 | 5.19 Million USD | 2.7% |
| 2018 FY | 3.48 Million USD | -29.23% |
| 2018 Q4 | 3.48 Million USD | 4.61% |
| 2018 Q3 | 3.32 Million USD | -35.9% |
| 2018 Q1 | 5.05 Million USD | 2.77% |
| 2017 Q4 | 4.91 Million USD | 2.6% |
| 2017 Q1 | 4.59 Million USD | 2.24% |
| 2017 Q3 | 4.79 Million USD | 2.14% |
| 2017 Q2 | 4.69 Million USD | 2.19% |
| 2017 FY | 4.91 Million USD | 9.49% |
| 2016 Q2 | 6.05 Million USD | -25.27% |
| 2016 Q4 | 4.49 Million USD | 2.31% |
| 2016 FY | 4.49 Million USD | -44.63% |
| 2016 Q1 | 8.09 Million USD | -0.18% |
| 2016 Q3 | 4.39 Million USD | -27.46% |
| 2015 Q2 | 7.89 Million USD | 1.31% |
| 2015 Q3 | 7.99 Million USD | 1.35% |
| 2015 FY | 8.11 Million USD | 5.49% |
| 2015 Q4 | 8.11 Million USD | 1.46% |
| 2015 Q1 | 7.78 Million USD | 1.27% |
| 2014 FY | 7.69 Million USD | -8.7% |
| 2014 Q1 | 7.45 Million USD | -11.52% |
| 2014 Q2 | 7.52 Million USD | 0.99% |
| 2014 Q3 | 7.6 Million USD | 1.05% |
| 2014 Q4 | 7.69 Million USD | 1.12% |
| 2013 Q3 | 4.03 Million USD | -51.57% |
| 2013 Q2 | 8.33 Million USD | 0.5% |
| 2013 Q1 | 8.29 Million USD | 26.9% |
| 2013 FY | 8.42 Million USD | 28.91% |
| 2013 Q4 | 8.42 Million USD | 108.71% |
| 2012 Q3 | 6.52 Million USD | -0.02% |
| 2012 Q4 | 6.53 Million USD | 0.07% |
| 2012 Q2 | 6.53 Million USD | 226.54% |
| 2012 Q1 | 2 Million USD | -73.18% |
| 2012 FY | 6.53 Million USD | -12.37% |
| 2011 FY | 7.45 Million USD | 0.0% |
| 2011 Q4 | 7.45 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 97.426% |
| Nemaura Medical Inc. | 20.03 Million USD | 30.4% |
| NeuroPace, Inc. | 72.39 Million USD | 80.743% |
| LENSAR, Inc. | 2.3 Million USD | -503.768% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -89.777% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -774.044% |
| Apyx Medical Corporation | 38.5 Million USD | 63.791% |
| Cutera, Inc. | 431.91 Million USD | 96.772% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 10.823% |
| BioSig Technologies, Inc. | 452 Thousand USD | -2984.292% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 64.454% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.171% |
| Axonics, Inc. | 27.61 Million USD | 49.52% |
| IRIDEX Corporation | 2.74 Million USD | -407.684% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 82.399% |
| TELA Bio, Inc. | 42.78 Million USD | 67.412% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -3678.049% |
| RxSight, Inc. | 3.01 Million USD | -362.849% |
| Align Technology, Inc. | 96.96 Million USD | 85.623% |
| INVO Bioscience, Inc. | 8.68 Million USD | -60.545% |
| electroCore, Inc. | 626 Thousand USD | -2126.997% |
| Telesis Bio, Inc. | 34.38 Million USD | 59.45% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -35.729% |
| Quipt Home Medical Corp. | 98.94 Million USD | 85.91% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 51.989% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -493.739% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 8.614% |
| Dynatronics Corporation | 6.68 Million USD | -108.449% |
| Modular Medical, Inc. | 1.19 Million USD | -1071.513% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -5220.992% |
| Talis Biomedical Corporation | 19.66 Million USD | 29.118% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -921.289% |
| InMode Ltd. | 9.01 Million USD | -54.608% |
| Envoy Medical, Inc. | 404 Thousand USD | -3350.743% |
| Bruker Corporation | 1.37 Billion USD | 98.989% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -24357.895% |
| DexCom, Inc. | 2.59 Billion USD | 99.463% |
| Nexalin Technology, Inc. | 4463.00 USD | -312268.362% |
| PAVmed Inc | 48.72 Million USD | 71.388% |
| Viveve Medical, Inc. | 5.34 Million USD | -160.628% |
| Cerus Corporation | 95.99 Million USD | 85.478% |
| Movano Inc. | 252 Thousand USD | -5432.143% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 57.976% |
| Nexalin Technology, Inc. | 4463.00 USD | -312268.362% |
| IceCure Medical Ltd | 599 Thousand USD | -2227.379% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 96.646% |
| enVVeno Medical Corporation | 1.4 Million USD | -894.365% |
| 908 Devices Inc. | 5.94 Million USD | -134.5% |
| Orthofix Medical Inc. | 134.19 Million USD | 89.612% |
| Surmodics, Inc. | 29.4 Million USD | 52.59% |
| Nuwellis, Inc. | 981 Thousand USD | -1321.101% |
| Outset Medical, Inc. | 136.18 Million USD | 89.763% |
| Venus Concept Inc. | 79.69 Million USD | 82.507% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 89.262% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 80.17% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -66.043% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -1382.587% |
| Inogen, Inc. | 21.92 Million USD | 36.409% |
| IRadimed Corporation | 2.04 Million USD | -582.364% |
| MaxCyte, Inc. | 18.74 Million USD | 25.62% |
| Pulmonx Corporation | 41.42 Million USD | 66.346% |
| PAVmed Inc. | 48.72 Million USD | 71.388% |
| iCAD, Inc. | 461 Thousand USD | -2924.078% |
| OrthoPediatrics Corp. | 23.76 Million USD | 41.326% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -598.272% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -2733.588% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -7460.195% |
| SI-BONE, Inc. | 38.99 Million USD | 64.247% |
| Semler Scientific, Inc. | 70 Thousand USD | -19815.714% |
| Beyond Air, Inc. | 17.83 Million USD | 21.842% |
| FONAR Corporation | 41.67 Million USD | 66.549% |
| AxoGen, Inc. | 69.29 Million USD | 79.881% |
| Biotricity, Inc. | 23.87 Million USD | 41.618% |
| Cytosorbents Corporation | 18.31 Million USD | 23.874% |
| ZimVie Inc. | 521.92 Million USD | 97.329% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 72.326% |
| Inari Medical, Inc. | 32.04 Million USD | 56.498% |
| UFP Technologies, Inc. | 46.03 Million USD | 69.718% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -598.272% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -353.947% |
| Sight Sciences, Inc. | 35.41 Million USD | 60.634% |
| Insulet Corporation | 1.44 Billion USD | 99.038% |
| Profound Medical Corp. | 7.9 Million USD | -76.46% |
| Bioventus Inc. | 409.47 Million USD | 96.595% |
| InspireMD, Inc. | 1.59 Million USD | -774.044% |
| BrainsWay Ltd. | 471 Thousand USD | -2859.873% |
| BIOLASE, Inc. | 17.91 Million USD | 22.161% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -1245.217% |
| Tenon Medical, Inc. | 1.17 Million USD | -1088.491% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1291.317% |
| CVRx, Inc. | 30.61 Million USD | 54.461% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.392% |
| Sintx Technologies, Inc. | 4.24 Million USD | -228.41% |
| Acutus Medical, Inc. | 38.47 Million USD | 63.77% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -598.797% |
| NanoVibronix, Inc. | 5000.00 USD | -278720.0% |
| Quanterix Corporation | 41.46 Million USD | 66.378% |
| LivaNova PLC | 640.4 Million USD | 97.823% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -366.166% |
| Varex Imaging Corporation | 469.5 Million USD | 97.031% |
| Vivani Medical, Inc. | 20.69 Million USD | 32.639% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -493.739% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -1680.46% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 98.507% |
| TransMedics Group, Inc. | 515.94 Million USD | 97.298% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -632.58% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -5687.625% |
| Spectral AI, Inc. | 1.28 Million USD | -981.536% |
| Hyperfine, Inc. | 185 Thousand USD | -7435.676% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 92.748% |
| Biomerica, Inc. | 785 Thousand USD | -1675.924% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3001.563% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -3666.769% |
| Silk Road Medical, Inc | 84.63 Million USD | 83.528% |